Advertisement

Topics

"Sonova Holding Strategy SWOT Corporate Finance Report Report" Drugs and Medication Database

00:00 EDT 26th March 2019 | BioPortfolio

Here are the most relevant "Sonova Holding Strategy SWOT Corporate Finance Report Report" Drugs and Medications that we have found in our database.

More Information about "Sonova Holding Strategy SWOT Corporate Finance Report Report" on BioPortfolio

We have published hundreds of Sonova Holding Strategy SWOT Corporate Finance Report Report news stories on BioPortfolio along with dozens of Sonova Holding Strategy SWOT Corporate Finance Report Report Clinical Trials and PubMed Articles about Sonova Holding Strategy SWOT Corporate Finance Report Report for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sonova Holding Strategy SWOT Corporate Finance Report Report Companies in our database. You can also find out about relevant Sonova Holding Strategy SWOT Corporate Finance Report Report Drugs and Medications on this site too.

Showing "Sonova Holding Strategy SWOT Corporate Finance Report Report" Drugs and Medications 1–25 of 33

Possibly Relevant

Nitrogen [indiana oxygen company, inc.]

NA

Trimo san [coopersurgical, inc.]

Trimo San

Sterile cord blood collection unit [medsep corporation]

Sterile Cord Blood Collection UnitCode 791-08

Glostrips [nomax inc.]

GloStrips 0.6 mg

Glostrips [nomax inc.]

GloStrips 1.0

Leucoflex cgp [maco productions]

Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD)With an Integral Container of Additive Solution (AS-1) Preservative,And an Integral Leucoflex CGP Leukocyte Reduction Filter for Red Blood Cells 

Glostrips [nomax inc.]

GloStrips

Mtl1 leucoflex [maco productions]

Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD) with an integral container of Additive Solution (AS-1) preservative, and an integral Leucoflex MTL1 Leukocyte Reduction Filter for Whole Blood

Humco strong iodine [humco holding group, inc.]

HUMCO Strong Iodine Solution (Lugol's Solution)

Ofloxacin [direct rx]

OFLOXACIN

Spiriva respimat [boehringer ingelheim pharmaceuticals, inc.]

These highlights do not include all the information needed to use SPIRIVA RESPIMAT safely and effectively. See full prescribing information for SPIRIVA RESPIMAT. SPIRIVA® RESPIMAT® (tiotropium bromide) inhalation spray, for oral inhalationInitial U.S. A

Grafco [gf health products, inc.]

NA

Grafco [gf health products, inc.]

NA

Grafco [gf health products, inc.]

NA

Sodium citrate blood-pack units, (pl 146 plastic) [fenwal, inc.]

Anticoagulant Sodium Citrate Solution, USP, BLOOD-PACKUnit

Ovace [mission pharmacal company]

Ovace Plus (sodium sulfacetamide 9.8%) Foam

Leukotrap wb system [haemonetics manufacturing inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Leukotrap wb system [haemonetics manufacturing inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Leukotrap wb system [haemonetics manufacturing inc]

Leukotrap WB System, CPDA-1 Blood Collection Set with WBF2 Filter and Sampling System

Avar [mission pharmacal company]

Avar (sodium sulfacetamide 9.5%, sulfur 5%) Foam

Avar ls [mission pharmacal company]

Avar LS (sodium sulfacetamide 10%, sulfur 2%) Foam

Firmagon [ferring pharmaceuticals inc.]

These highlights do not include all the information needed to use FIRMAGON (degarelix for injection) safely and effectively. See full prescribing information for FIRMAGON. FIRMAGON (degarelix for injection) for subcutaneous administration Initial U.S. App

Cpda-1 blood collection system [haemonetics manufacturing inc]

CPDA-1 Blood Collection Set with Sampling System

Cpda-1 blood collection system [haemonetics manufacturing inc]

CPDA-1 Blood Collection Set with Sampling System

Eskata [aclaris therapeutics, inc.]

These highlights do not include all the information needed to use ESKATA™ safely and effectively. See full prescribing information for ESKATA™. ESKATA™ (hydrogen peroxide) topical solutionInitial U.S. Approval: 2017



Advertisement
Quick Search
Advertisement
Advertisement